This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: The Ohio State University, University of Freiburg. Active years: 2019.
Company Filing History:
1 out of 1,575 
1 out of 1 Years Active: 2019
Title: Simon Kirste: Innovator in Prostate Cancer Diagnostics
Introduction
Simon Kirste is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of cancer diagnostics, particularly in prostate cancer. His innovative work focuses on the development of predictive models that can enhance treatment decisions for patients.
Latest Patents
Simon Kirste holds a patent for "MiRNA-based predictive models for diagnosis and prognosis of prostate cancer." This invention addresses the challenge of subjective decision-making in prostate cancer treatment due to the lack of clear predictors of disease progression. His research identifies new biomarkers, specifically miRNAs, that can be utilized to detect or predict the progression of prostate cancer. This advancement aims to improve treatment plans and outcomes for patients. Additionally, the patent includes kits designed for the detection of these miRNAs.
Career Highlights
Throughout his career, Simon Kirste has worked with esteemed organizations such as the Ohio State Innovation Foundation and the University of Freiburg. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Simon Kirste's notable coworkers include Arnab Chakravarti and Erica McKenzie Bell. Their collaborative efforts have furthered the understanding and development of innovative solutions in cancer diagnostics.
Conclusion
Simon Kirste's work in miRNA-based predictive models represents a significant advancement in the diagnosis and prognosis of prostate cancer. His contributions are poised to make a lasting impact on the field of oncology and improve patient care.